(Total Views: 239)
Posted On: 07/21/2023 2:40:46 PM
Post# of 194

$ABBV News Article - AbbVie Receives Positive CHMP Opinion for Epcoritamab (TEPKINLY ) for the Treatment of Adults with Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL) https://marketwirenews.com/news-releases/abbv...53322.html


My Twitter: WhyteStocks